Till Holsten

1PUBLICATIONS
1CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Feb 23, 2022
ALK inhibition as a salvage therapy for a relapsed unclassifiable sarcomatous CNS tumor with EML4/ALK fusion in an infant.

Till Holsten, Annika Bronsema, Dominik Sturm

Pageof 1

Frequent Collaborators